Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

February 03, 2026 01:00 ET | Source: Pharming Group N.V.

Pharming Group announces 2026 financial guidance and highlights rare disease pipeline at Investor Day

Pharming Group announces 2026 financial guidance and highlights rare disease pipeline (PIDs and PMD) at Investor Day today Feb. 3 at 10:00am EST.
January 08, 2026 01:00 ET | Source: Pharming Group N.V.

Pharming Group reports preliminary 2025 revenues and announces Investor Day

Pharming announced preliminary, unaudited revenues for the full year 2025 and plans to host a virtual Investor Day on February 3, 2026 at 10:00 EST.
November 06, 2025 01:00 ET | Source: Pharming Group N.V.

Pharming Group reports third quarter 2025 financial results with significant growth in revenue, profitability and cash flow

Pharming Group reports Q3 2025 results with significant growth in revenue, profit, and cash flow driven by rare disease portfolio performance.
November 07, 2024 07:00 ET | Source: Khondrion

Khondrion announces publication in Brain of integrated Phase 2b program demonstrating disease-modifying potential of sonlicromanol in primary mitochondrial disease

NIJMEGEN, the Netherlands – 7 November 2024: Khondrion, a clinical stage biopharmaceutical company discovering and developing therapies targeting primary mitochondrial disease (PMD), today announced...